Clopidogrel monotherapy is associated with higher mortality risk compared to aspirin: a retrospective analysis of NHANES 1999–2018
Background Clopidogrel and aspirin are widely used antiplatelet agents. Although clopidogrel resistance is more prevalent in Asian populations, a Korean study suggested that clopidogrel was superior to aspirin in patients who completed standard dual antiplatelet therapy following percutaneous corona...
Saved in:
Main Authors: | Tieshi Zhu, Yong He, Yuzhang Bei, Hui Mai, Le Zhao |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-12-01
|
Series: | Platelets |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/09537104.2025.2532454 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Relationship of prognostic nutritional index with anemia and all-cause mortality: a NHANES study
by: Yongjin Zhi, et al.
Published: (2025-12-01) -
Association between albumin to globulin ratio and all-cause and cardiovascular mortality among individuals with cardiovascular-kidney-metabolic syndrome: results from NHANES 2003 to 2018
by: Guangyu Wang, et al.
Published: (2025-07-01) -
Association between body roundness index and risks of all-cause and cardiovascular mortality in adults with metabolic dysfunction-associated steatotic liver disease: NHANES 1999–2018
by: Yanshan Yi, et al.
Published: (2025-07-01) -
Efficacy and Safety of Dual Antiplatelet Therapy Using Cilostazol with Aspirin or Clopidogrel to Reduce the Rate of Recurrent Ischemic Stroke in Asia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Hendrawan Chandra Kusuma, et al.
Published: (2025-05-01) -
Efficacy and Safety of Dual Antiplatelet Therapy Using Cilostazol with Aspirin or Clopidogrel to Reduce the Rate of Recurrent Ischemic Stroke in Asia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Hendrawan Chandra Kusuma, et al.
Published: (2025-05-01)